Brief: Valbiotis: Implementation Of Totum 63 At Laval University In Quebec City
June 28 (Reuters) - Valbiotis SA ALVAL.PA :
* VALBIOTIS ANNOUNCES THE IMPLEMENTATION OF THE TOTUM•63
MODE OF
ACTION CLINICAL STUDY BY INAF1 AT LAVAL UNIVERSITY IN QUEBEC
CITY, IN PARTNERSHIP WITH NESTLÉ HEALTH SCIENCE
* STUDY WILL EXPLORE MODE OF ACTION OF TOTUM•63 IN HUMANS
* ITS LAUNCH IS SCHEDULED FOR 4TH QUARTER OF 2021 IN CANADA
Source text for Eikon: ID:nBw6sHrJa
Further company coverage: ALVAL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Valbiotis SA
See all newsBrief: Valbiotis Announces Creation By Chinese JV Of Subsidiary In Singapore
French and Benelux stocks-Factors to watch
Brief: Valbiotis FY Operating Profit Eur -9.5 Mln
Brief: Valbiotis Launches Capital Increase For Gross Amount Of Nearly EUR 6.9 Mln
Brief: Valbiotis Signs Strategic Agreements With Two Pharmaceutical Groups